Phase II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and Trastuzumab

NCT00532857 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

53

Enrollment

OTHER_GOV

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Paclitaxel/Gemcitabine/Trastuzumab

Sponsor

Jungsil Ro